IgE antibodies recruit macrophages through the TNFα/MCP-1 signaling pathway, enhancing the anti-tumor immune response and thereby inhibiting the growth of ovarian cancer (74) (Figure 2). This evidence concerns the gene CCL2 and neoplasm.